Bulletin
Investor Alert

Pfizer Inc.

NYS: PFE

GO
/marketstate/country/us

After Hours

PFE
/zigman2/quotes/202877789/composite

$

43.07

Change

-0.09 -0.21%

Volume

Volume 504,703

Oct 22, 2021, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202877789/composite

Previous close

$ 42.86

$ 43.16

Change

+0.30 +0.70%

Day low

Day high

$42.63

$43.19

Open
Open: 42.82

52 week low

52 week high

$32.78

$51.86

Open

Market cap

$240.30B

Average volume

30.63M

P/E ratio

18.48

Rev. per Employee

$533,860

EPS

2.34

Dividend

0.39

Div yield

3.61%

Ex dividend date

11/4/21

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/pfe

MarketWatch News on PFE

  1. Johnson & Johnson stock outperforms competitors on strong trading day

    4:32 p.m. Oct. 22, 2021

    - MarketWatch Automation

  2. Pfizer and BioNTech Vaccine Is Nearly 91% Effective in Children

    10:32 a.m. Oct. 22, 2021

    - Sabrina Escobar

  3. Mix-and-Match Booster Rollout Set to Start

    8:17 a.m. Oct. 22, 2021

    - Josh Nathan-Kazis

  4. CDC approves expanded rollout of COVID-19 boosters

    9:05 p.m. Oct. 21, 2021

    - Associated Press

  5. CDC Advisers Back Mixing Covid-19 Boosters

    6:12 p.m. Oct. 21, 2021

    - Josh Nathan-Kazis

  6. Johnson & Johnson stock underperforms Thursday when compared to competitors

    4:32 p.m. Oct. 21, 2021

    - MarketWatch Automation

  7. Merck Scores Unexpectedly in Pneumococcal Vaccine Fight With Pfizer

    11:39 a.m. Oct. 21, 2021

    - Josh Nathan-Kazis

  8. Pfizer Booster Restores Efficacy to Near 96%

    9:30 a.m. Oct. 21, 2021

    - Sabrina Escobar

  9. Pfizer and BioNTech plan to submit data to FDA, EMA and other regulatory bodies

    6:48 a.m. Oct. 21, 2021

    - Ciara Linnane

  10. Pfizer and BioNTech says trial involved more than 10,000 participants 16 years and older

    6:48 a.m. Oct. 21, 2021

    - Ciara Linnane

  11. Pfizer and BioNTech say Phase 3 trial found booster dose of COVID vaccine had 95.6% efficacy against disease

    6:47 a.m. Oct. 21, 2021

    - Ciara Linnane

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/pfe

Other News on PFE

  1. The Unlikely Outsiders Who Won the Race for a Covid-19 Vaccine

    12:00 a.m. Today

    - Gregory Zuckerman

  2. Why Novavax Fell by 3% Today

    5:02 p.m. Oct. 22, 2021

    - Motley Fool

  3. Are Covid-19 Vaccines Safe for Kids? What Parents Should Know

    10:30 a.m. Oct. 22, 2021

    - Robbie Whelan

  4. Wall Street Breakfast: U.S. Home Sales Surge (Podcast)

    8:18 a.m. Oct. 22, 2021

    - Seeking Alpha

  5. Wall Street Breakfast: Ad-Mageddon

    7:11 a.m. Oct. 22, 2021

    - Seeking Alpha

  6. What's the Outlook for Novavax Stock?

    6:05 a.m. Oct. 22, 2021

    - Motley Fool

  7. Moderna and J&J Covid-19 Booster Shots Backed by CDC

    11:17 p.m. Oct. 21, 2021

    - Felicia Schwartz

  8. Why BioNTech Stock Jumped Today

    3:50 p.m. Oct. 21, 2021

    - Motley Fool

  9. EU to issue decision on Moderna COVID-19 booster shot next week

    1:40 p.m. Oct. 21, 2021

    - Seeking Alpha

  10. Should I Get a Covid-19 Vaccine Booster Shot? What to Know

    12:27 p.m. Oct. 21, 2021

    - Felicia Schwartz

  11. Loading more headlines...
/news/pressrelease/company/us/pfe

Press Releases on PFE

  1. Hospital Pharmaceuticals Market Rewriting Long Term Growth Story

    12:28 p.m. July 30, 2021

    - Heraldkeepers

  2. Optometry Market Size, Share, Trends, Analysis and Forecast 2027

    7:49 a.m. July 30, 2021

    - Market Insight Reports

  3. Endocrinology Drugs Market Size, Share, Trends, Analysis and Forecast 2027

    5:59 a.m. July 30, 2021

    - Market Insight Reports

  4. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.01%
  • /zigman2/quotes/200164174/composite SNOA+85.40%
  • /zigman2/quotes/202092269/composite ENSC+35.46%
  • /zigman2/quotes/226465160/composite ALF-14.72%
  • /zigman2/quotes/207732364/composite MSFT+1.66%
X
Powered by StockTwits
Link to MarketWatch's Slice.